Skip to content

HOME
OUR IMMUNE SYSTEM
IMMUNOTHERAPY
DEFINITION
COMPLEMENTARIES
PROCEDURE
INDICATIONS
LINKS
PUBLICATIONS
CONTACT US

Related Publications

Categories

Categories

A Potential Surrogate Marker of Efficacy for a Therapeutic Melanoma Vaccine

By eliezer / October 10, 2024

Post navigation

Antiidiotype (Ab2) Vaccine Therapy for Cutaneous T-Cell Lumphoma

Enhancement of a Spontaneous Immune Response Against a B-Cell Lymphoma by Dendritic Cells Leads to Protection Against the Tumor

HOME
OUR IMMUNE SYSTEM
IMMUNOTHERAPY
DEFINITION
COMPLEMENTARIES
PROCEDURE
INDICATIONS
LINKS
PUBLICATIONS
CONTACT US

Brought to you by:

Endorsed by:

Copyright © 2024 FCTI, Inc. All Rights Reserved.

Glossary of Terms

Disclaimer

Privacy Statement

Scroll to Top